CTMX

CytomX Therapeutics (CTMX)

CytomX Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CTMX

<< 前へ 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2017/02/02	22 : 00	GlobeNewswire Inc.	CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	06 : 54	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	03 : 56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	03 : 55	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	03 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	03 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/28	03 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/27	06 : 52	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/11	06 : 58	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/10	08 : 55	GlobeNewswire Inc.	UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
2017/01/09	22 : 00	GlobeNewswire Inc.	CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/30	05 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/14	22 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/14	22 : 00	GlobeNewswire Inc.	CytomX Announces U.S. FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Study of Anti-PD-L1 Probod...	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/13	22 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/13	22 : 00	GlobeNewswire Inc.	CytomX Announces Selection by Bristol-Myers Squibb of First Clinical Candidate Probody From Collaboration	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/08	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/05	22 : 03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/05	22 : 00	GlobeNewswire Inc.	CytomX Announces Fourth Target Selection by Bristol-Myers Squibb Under Strategic Oncology Collaboration	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/02	04 : 36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/12/02	04 : 28	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/29	07 : 51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/29	07 : 11	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/23	22 : 03	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/23	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/22	08 : 49	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/15	07 : 53	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/15	07 : 07	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/11	06 : 42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc
2016/11/11	06 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:CTMX	CytomX Therapeutics Inc